| Literature DB >> 27893743 |
Michael Politis1, Denise Wajnsztajn1, Boris Rosin1, Colin Block2, Abraham Solomon1.
Abstract
PURPOSE: To describe the trends in pathogens and antibacterial resistance of corneal culture isolates in infectious keratitis during a period of 13 years at Hadassah-Hebrew University Medical Center.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27893743 PMCID: PMC5125568 DOI: 10.1371/journal.pone.0165223
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Bacterial keratitis culture distribution per year 2002–2014.
Fig 2(A) Shifting proportions of bacterial keratitis isolates by year period 2002–2014. (B) Trends of bacterial keratitis isolates by year period 2002–2014.
Trend analysis of bacterial keratitis isolates by year period 2002–2014.
| Common bacterial isolate | 2002–2005 | 2006–2009 | 2010–2014 | APC | P value |
|---|---|---|---|---|---|
| Grand Total | 155 | 119 | 157 | -1.6 | 0.3 |
| Coagulase-negative staphylococci | 68 | 33 | 37 | -8.1 | 0.002 |
| Pseudomonas aeruginosa | 27 | 26 | 25 | -5.3 | 0.1 |
| Streptococcus pneumoniae | 13 | 21 | 22 | 7.4 | 0.2 |
| Staphylococcus aureus | 11 | 15 | 16 | -0.8 | 0.9 |
| MRSA | 2 | 1 | 0 | -31.2 | 0.5 |
| MSSA | 9 | 14 | 16 | 7.5 | 0.2 |
| Haemophilus influenzae | 4 | 3 | 2 | -8.3 | 0.1 |
| Streptococcus species | 4 | 5 | 3 | -3.5 | 0.5 |
| Escherichia coli | 1 | 1 | 3 | 14.7 | 0.1 |
*APC: Annual Percent Change
Trend analysis of antibiotic resistance for common pathogens.
| 2002–2005 | 2006–2009 | 2010–2014 | APC | P value | |||||
|---|---|---|---|---|---|---|---|---|---|
| % | N | % | N | % | N | ||||
| Amikacin | 0% | 0 | 0% | 0 | 0% | 0 | 0.00 | >0.05 | |
| Cetazidime | 0% | 0 | 0% | 0 | 0% | 0 | 0.00 | >0.05 | |
| Ciprofloxacin | 0% | 0 | 8% | 2 | 0% | 0 | 0.00 | >0.05 | |
| Gentamicin | 7% | 2 | 12% | 3 | 0% | 0 | -31.20 | 0.4 | |
| Chloramphenicol | 18% | 2 | 7% | 1 | 0% | 0 | -31.20 | 0.2 | |
| Ciprofloxacin | 0% | 0 | 0% | 0 | 0% | 0 | 0.00 | >0.05 | |
| Gentamicin | 9% | 1 | 7% | 1 | 6% | 1 | 0.00 | >0.05 | |
| Oxacilin/methicilin | 18% | 2 | 7% | 1 | 0% | 0 | -31.20 | 0.2 | |
| Penicilin | 9% | 1 | 13% | 2 | 6% | 1 | 0.00 | >0.05 | |
| Vancomycin | 0% | 0 | 0% | 0 | 0% | 0 | 0.00 | >0.05 | |
| Chloramphenicol | 13% | 9 | 27% | 9 | 5% | 2 | -17.10 | 0.3 | |
| Ciprofloxacin | 0% | 0 | 6% | 2 | 14% | 5 | 63.10 | 0.2 | |
| Gentamicin | 13% | 9 | 9% | 3 | 16% | 6 | -4.90 | 0.8 | |
| Penicilin | 28% | 19 | 70% | 23 | 76% | 28 | 5.00 | <0.001 | |
| Vancomycin | 0% | 0 | 0% | 0 | 0% | 0 | 0.00 | >0.05 | |
| Ceftriaxone | 0% | 0 | 0% | 0 | 0% | 0 | 0.00 | >0.05 | |
| Chloramphenicol | 0% | 0 | 0% | 0 | 0% | 0 | 0.00 | >0.05 | |
| Penicilin | 8% | 1 | 43% | 9 | 50% | 11 | 35.00 | 0.3 | |
| Vancomycin | 0% | 0 | 0% | 0 | 0% | 0 | 0.00 | >0.05 | |
| Cefazolin | 8% | 12 | 4% | 5 | 4% | 7 | -6.50 | 0.6 | |
| Gentamycin | 8% | 12 | 6% | 7 | 6% | 10 | -2.30 | 0.8 | |
| Vancomycin | 0% | 0 | 0% | 0 | 0% | 0 | 0.00 | >0.05 | |
| Ciprofloxacin | 0% | 0 | 3% | 4 | 5% | 8 | 72.90 | 0.2 | |
*APC: Annual Percent Change
Fig 3Proportion of Positives Corneal Isolates in a 24-hour period during 2002–2014.
Literature review summary table.
| Author | Year published | Follow-up (Years) | Location | Number of corneal scrapes | Comments |
|---|---|---|---|---|---|
| Alexandrakis G et al. | 2000 | 9 | Florida | 2920 | Increase in number of S. aureus keratitis in the study period. |
| Decrease in the number of Pseudomonas aeruginosa keratitis in the study period | |||||
| Increasing laboratory resistance of S. Aureus keratitis isolates to fluoroquinolones | |||||
| Lalitha et al. | 2014 | 11 | India | 5912 | Annual number of keratitis cases due to bacteria decrease and the annual number due to fungus increased |
| Lichtinger et al. | 2012 | 11 | Toronto | 1701 | Decrease trend in Gram-positive isolates |
| Most common isolate overall was coagulase-negative Staphylococcus | |||||
| Increase trend toward laboratory resistance to methicillin | |||||
| MRSA was resistant to cefazolin and sensitive to vancomycin in all isolates | |||||
| Sand et al. | 2015 | 4 | Los Angeles | 290 | Coagulase negative Staphylococcus most common gram-positive isolate, Pseudomonas aeruginosa most common gram-negative isolate |
| Ciprofloxacin and levofloxacin was susceptible on all tested pathogens in 73% and 81% respectively | |||||
| Shalchi Z et al. | 2011 | 10 | UK | 476 | Increase in the number of gram-negative isolates in the study period |
| In vitro wide spread gram-negative resistance to chloramphenicol | |||||
| No increase trend found on ciprofloxacin resistance | |||||
| 97.3% of isolates were sensitive to combination of gentamicin and cefuroxime | |||||
| Zhang et al. | 2008 | 4 | China | 279 | Pseudomonas sp. most common organism isolated |
| Ciprofloxacin showed the highest rate of resistance in all isolates | |||||
| The resistance of isolates from patients older than 60Y to ciprofloxacin, levofloxacin and tobramycin was higher that from younger adults (14–59) | |||||
| Hong J et al. | 2013 | 6 | Shanghai | 436 | Most common isolate Streptococcus species |
| MRSA was found in 8.3% of the S. Aureus isolates | |||||
| Increase trend toward laboratory resistance to fluoroquinolones | |||||
| No resistance found for Gram-positive isolates to vancomycin | |||||
| Hernandez-Camarena JC et al. | 2015 | 10 | Mexico city | 616 | Most common isolated pathogen was Staphylococcus epidermidis |
| Non-significant increasing trend on Gram-negative isolates | |||||
| MRSA was present in 45% out of the total S. Aurues isolates | |||||
| Increasing resistance to ceftazidime for Pseudomonas aeruginosa | |||||
| Lavinsky F et al. | 2013 | 3 | Tel Aviv, Israel | 276 | Staphylococcus aureus was the most common isolate found on corneal scrapings |
| Orlans HO et al. | 2011 | 10 | UK | 467 | Most common isolate Staphylococci sp. |
| Increase in the number of Coagulase-negative Staphylococci isolates | |||||
| Increase resistance of non-Pseudomonas Gram-negative isolates to chloramphenicol | |||||
| 93.2% of all isolates were susceptible to ciprofloxacin and 99.5% to either gentamicin or cefuroxime | |||||
| Ng AL-K et al. | 2015 | 10 | Hong Kong | 347 | Most common isolate overall was coagulase-negative Staphylococcus |
| Fluoroquinolone was found susceptible in 93.6% of al Gram-negative and in 100% of all Pseudomonas aeruginosa | |||||
| No emergence of resistant strain during the study period | |||||
| Ibrahim MM et al. | 2011 | 3 | Brazil | 118 | Predominant bacterial pathogen isolated was S. Epidermidis |
| Chang VS et al. | 2015 | 20 | Pittsburgh,USA | 398 | Analyzed only antibiotic susceptibility to MRSA and MSSA keratitis |
| MRSA represented 30.7% of total S. aureus isolates | |||||
| Vancomycin was susceptible to all S. aureus | |||||
| MRSA was found more resistant to second-generation fluoroquinolones than to the fourth-generation fluoroquinolones | |||||
| Increase in resistance to fourth-generation fluoroquinolone was detected during the study period for MSSA and MRSA | |||||
| Politis et al. | 13 | Jerusalem,Israel | 943 | Cultures were recovered in 48% of all cultures | |
| Most common isolate overall was coagulase-negative Staphylococcus | |||||
| Significant decrease trend in cases of coagulase-negative Staphylococcus (APC -8.1) | |||||
| Increase trend of coagulase-negative Staphylococcus resistance to penicillin. | |||||
| Vancomycin was susceptible to all pathogens | |||||
| Inverted correlation between temperature and number of cases of bacterial keratitis |
Fig 4Comparison of positive culture isolates in the published literature.